xAnts

xAnts

en-ZA

Novo Nordisk expands AI partnership with Valo Health for development of obesity drugs

2025-01-08

health

Novo Nordisk expands AI partnership with Valo Health for development of obesity drugs

Danish drugmaker Novo Nordisk and U.S. tech firm Valo Health said on Wednesday they were expanding their 2023 agreement to develop new treatments for cardiometabolic diseases using human data and artificial intelligence (AI). ...Read more

Recommendations